hotspot -WSS

hotspot

author：explore 2025-10-01 22:58:32 - browse：5439

US Capitol - SOTU — Lawmakers in Congress have decided to punt efforts to reform how PBMs operate. BRENDAN SMIALOWSKI/AFP/Getty Images

WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an upcoming package to fund the federal government, 11 lobbyists and sources following the talks told STAT.

It’s a missed opportunity to pass one of the health care priorities that has attracted the most bipartisan interest and activity this Congress, though lawmakers could revive the negotiations on the issues in the future.

Reforming how pharmacy benefit managers operate has been a top lobbying priority for the pharmaceutical industry since Democrats passed a major package aimed at lowering the costs of medicines in 2022. Pharma and PBMs have taken up a very public battle on the airwaves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Sage considers ways to reduce costs following FDA rejection

WSS

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

HIV drugs protect against transmission, even in unprotected sex

Failure, not just success, should guide future doctors

St. Louis police protesters begin picking up checks in $4.9 million settlement

Woman returns to dialysis after doctors remove transplanted pig kidney

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

leisure time

hotspot

focus

Anesthesiologist group: stop taking Ozempic before surgery

Failure, not just success, should guide future doctors

The high cost of giving birth even with insurance

With heat waves through August, officials warn of health risks

BioMarin wins approval for gene therapy to treat hemophilia A

How to increase colonoscopy rates? Looks like an AI can help

Malaria cases in Florida and Texas: Here’s what you need to know

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Hepatitis C has a cure — but many Americans still lack access to it

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

hotspot

Sweden knocks USA out of World Cup in penalty kicks

Judge in Trump's classified documents case questions use of out

NFL doctors' conflicts of interest could endanger players, report says

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Paxlovid rebound happens. Why and to whom are still a mystery

Innovation in antibiotics is ailing. 'Brain drain' may kill it

leisure time

hotspot

focus

leisure time